Genetic and clinical landscape of ER + /PR- breast cancer in China

BACKGROUND: Estrogen receptor-positive and progesterone receptor-negative (ER + /PR-) breast cancer comprise a special type. More than 10% breast cancer patients belonged to ER + /PR-. METHODS: In order to better understand this patient population, we utilized a unique dataset from China, examining...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Danian, Wu, Hongmei, Zhuang, Hongkai, Chen, Rong, Long, Cheng, Chen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696783/
https://www.ncbi.nlm.nih.gov/pubmed/38049758
http://dx.doi.org/10.1186/s12885-023-11643-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696783/
https://www.ncbi.nlm.nih.gov/pubmed/38049758
http://dx.doi.org/10.1186/s12885-023-11643-2

Ejemplares similares